Balulao, Albert D.
HRN: 25-93-14 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/11/2025
11/18/2025
IV
4.5G
Q6
SEPSIS
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes